Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family
NR 566 Advanced Pharmacology for Care of
the Family Midterm Examination 2026/2027
| Verified Questions
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family | University-
Level Advanced Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family
Midterm Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
,INTRODUCTION
This Midterm Comprehensive Examination contains 100 original verified questions designed for
university-level advanced nursing students enrolled in NR 566 Advanced Pharmacology for Care of the
Family at Chamberlain College of Nursing. The questions are distributed equally across four core
domains: Pharmacologic Principles Across the Lifespan (25 questions), Cardiovascular and Respiratory
Pharmacology in Family Care (25 questions), Neurological, Psychiatric, and Pain Management
Pharmacology (25 questions), and Endocrine, Gastrointestinal, and Musculoskeletal Pharmacology (25
questions). Content is aligned with the official NR 566 midterm course objectives for the 2026/2027
academic year and draws upon foundational advanced pharmacology principles from established
prescribing and therapeutics frameworks. The examination is constructed to reinforce lifespan
pharmacokinetics and pharmacodynamics, cardiovascular and respiratory prescribing, neuropsychiatric
and analgesic pharmacotherapy, and endocrine-GI-musculoskeletal drug management essential for actual
exam readiness and clinical proficiency.
ACTUAL QUESTIONS
Domain 1: Pharmacologic Principles Across the Lifespan
Question 1. Pharmacokinetics in older adults is most often characterized by:
A. Reduced renal clearance, altered body composition, and increased sensitivity to many agents
B. Increased hepatic blood flow and faster clearance of all drugs
C. No clinically relevant age-related changes
D. Uniformly increased first-pass metabolism
Correct Answer: A
Rationale: Aging commonly reduces GFR, alters fat/lean mass, and increases sensitivity to CNS and
cardiovascular drugs, requiring dose adjustment and careful monitoring.
Question 2. A drug with a high first-pass effect will have:
A. Higher oral bioavailability than IV bioavailability
B. Lower oral bioavailability compared with intravenous administration
C. Identical exposure by all routes
D. No metabolism in the liver
Correct Answer: B
Rationale: Extensive first-pass hepatic metabolism reduces the fraction of an oral dose that reaches
systemic circulation.
Question 3. Which statement best describes a prodrug?
A. A drug that is active as administered and never metabolized
B. A drug that only works topically
C. A compound that is inactive (or less active) as given and is converted in the body to an active
metabolite
D. An agent that cannot cross membranes
Correct Answer: C
Rationale: Prodrugs require metabolic activation to produce the therapeutic moiety (e.g., clopidogrel,
codeine to morphine via CYP2D6).
Question 4. Volume of distribution (Vd) is increased for lipophilic drugs in older adults
primarily because of:
A. Increased total body water
B. Decreased plasma protein binding of all drugs equally
C. Faster renal excretion
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
, D. Increased body fat proportion
Correct Answer: D
Rationale: Higher fat mass expands Vd for lipophilic drugs, which can prolong half-life and affect
loading and maintenance dosing.
Question 5. A narrow therapeutic index drug requires:
A. Careful dosing and monitoring because small changes in concentration can cause toxicity or loss of
effect
B. No laboratory monitoring
C. Unlimited dose escalation without regard to levels
D. Only once-lifetime prescribing
Correct Answer: A
Rationale: Narrow therapeutic index agents (e.g., warfarin, digoxin, lithium, some AEDs) demand
individualized dosing and monitoring.
Question 6. CYP2D6 poor metabolizer status most affects:
A. Drugs cleared only by glomerular filtration
B. Only topical drug absorption
C. Activation of certain prodrugs (e.g., codeine, tamoxifen) and clearance of CYP2D6 substrates
D. Renal tubular secretion exclusively
Correct Answer: C
Rationale: CYP2D6 PM phenotype reduces activation of codeine to morphine and alters exposure to
many antidepressants, beta-blockers, and other substrates.
Question 7. Protein binding displacement interactions are most clinically important when:
A. Neither drug binds protein
B. Both drugs are highly protein-bound, have narrow therapeutic indices, and clearance is affected
C. Only hydrophilic drugs are involved
D. The patient is young and healthy with normal albumin
Correct Answer: B
Rationale: Displacement can transiently raise free fraction; clinical impact is greatest with narrow-
index, highly bound drugs and concurrent clearance changes.
Question 8. Pediatric dosing is frequently based on:
A. Weight (mg/kg) or body surface area, with attention to developmental pharmacology
B. Adult dose regardless of size
C. Only age in years without weight
D. Fixed tablet strengths for all ages
Correct Answer: A
Rationale: Children require weight- or BSA-based dosing and consideration of immature renal/hepatic
function, especially in neonates and infants.
Question 9. Steady state for a drug dosed at a fixed interval is generally reached after
approximately:
A. One half-life
B. Twenty half-lives
C. Thirty minutes regardless of half-life
D. Four to five half-lives
Correct Answer: D
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
NR 566 Advanced Pharmacology for Care of
the Family Midterm Examination 2026/2027
| Verified Questions
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family | University-
Level Advanced Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 566 Advanced Pharmacology for Care of the Family
Midterm Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
,INTRODUCTION
This Midterm Comprehensive Examination contains 100 original verified questions designed for
university-level advanced nursing students enrolled in NR 566 Advanced Pharmacology for Care of the
Family at Chamberlain College of Nursing. The questions are distributed equally across four core
domains: Pharmacologic Principles Across the Lifespan (25 questions), Cardiovascular and Respiratory
Pharmacology in Family Care (25 questions), Neurological, Psychiatric, and Pain Management
Pharmacology (25 questions), and Endocrine, Gastrointestinal, and Musculoskeletal Pharmacology (25
questions). Content is aligned with the official NR 566 midterm course objectives for the 2026/2027
academic year and draws upon foundational advanced pharmacology principles from established
prescribing and therapeutics frameworks. The examination is constructed to reinforce lifespan
pharmacokinetics and pharmacodynamics, cardiovascular and respiratory prescribing, neuropsychiatric
and analgesic pharmacotherapy, and endocrine-GI-musculoskeletal drug management essential for actual
exam readiness and clinical proficiency.
ACTUAL QUESTIONS
Domain 1: Pharmacologic Principles Across the Lifespan
Question 1. Pharmacokinetics in older adults is most often characterized by:
A. Reduced renal clearance, altered body composition, and increased sensitivity to many agents
B. Increased hepatic blood flow and faster clearance of all drugs
C. No clinically relevant age-related changes
D. Uniformly increased first-pass metabolism
Correct Answer: A
Rationale: Aging commonly reduces GFR, alters fat/lean mass, and increases sensitivity to CNS and
cardiovascular drugs, requiring dose adjustment and careful monitoring.
Question 2. A drug with a high first-pass effect will have:
A. Higher oral bioavailability than IV bioavailability
B. Lower oral bioavailability compared with intravenous administration
C. Identical exposure by all routes
D. No metabolism in the liver
Correct Answer: B
Rationale: Extensive first-pass hepatic metabolism reduces the fraction of an oral dose that reaches
systemic circulation.
Question 3. Which statement best describes a prodrug?
A. A drug that is active as administered and never metabolized
B. A drug that only works topically
C. A compound that is inactive (or less active) as given and is converted in the body to an active
metabolite
D. An agent that cannot cross membranes
Correct Answer: C
Rationale: Prodrugs require metabolic activation to produce the therapeutic moiety (e.g., clopidogrel,
codeine to morphine via CYP2D6).
Question 4. Volume of distribution (Vd) is increased for lipophilic drugs in older adults
primarily because of:
A. Increased total body water
B. Decreased plasma protein binding of all drugs equally
C. Faster renal excretion
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
, D. Increased body fat proportion
Correct Answer: D
Rationale: Higher fat mass expands Vd for lipophilic drugs, which can prolong half-life and affect
loading and maintenance dosing.
Question 5. A narrow therapeutic index drug requires:
A. Careful dosing and monitoring because small changes in concentration can cause toxicity or loss of
effect
B. No laboratory monitoring
C. Unlimited dose escalation without regard to levels
D. Only once-lifetime prescribing
Correct Answer: A
Rationale: Narrow therapeutic index agents (e.g., warfarin, digoxin, lithium, some AEDs) demand
individualized dosing and monitoring.
Question 6. CYP2D6 poor metabolizer status most affects:
A. Drugs cleared only by glomerular filtration
B. Only topical drug absorption
C. Activation of certain prodrugs (e.g., codeine, tamoxifen) and clearance of CYP2D6 substrates
D. Renal tubular secretion exclusively
Correct Answer: C
Rationale: CYP2D6 PM phenotype reduces activation of codeine to morphine and alters exposure to
many antidepressants, beta-blockers, and other substrates.
Question 7. Protein binding displacement interactions are most clinically important when:
A. Neither drug binds protein
B. Both drugs are highly protein-bound, have narrow therapeutic indices, and clearance is affected
C. Only hydrophilic drugs are involved
D. The patient is young and healthy with normal albumin
Correct Answer: B
Rationale: Displacement can transiently raise free fraction; clinical impact is greatest with narrow-
index, highly bound drugs and concurrent clearance changes.
Question 8. Pediatric dosing is frequently based on:
A. Weight (mg/kg) or body surface area, with attention to developmental pharmacology
B. Adult dose regardless of size
C. Only age in years without weight
D. Fixed tablet strengths for all ages
Correct Answer: A
Rationale: Children require weight- or BSA-based dosing and consideration of immature renal/hepatic
function, especially in neonates and infants.
Question 9. Steady state for a drug dosed at a fixed interval is generally reached after
approximately:
A. One half-life
B. Twenty half-lives
C. Thirty minutes regardless of half-life
D. Four to five half-lives
Correct Answer: D
NR 566 Advanced Pharmacology for Care of the Family Midterm Examination 2026/2027 | Verified Questions
